Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 168,733 $ 193,598
Accounts receivable, net 220,284 193,875
Inventory, net 47,228 39,681
Other current assets and prepaid expenses 47,356 26,904
Total current assets 483,601 454,058
Property, plant and equipment, net 122,831 131,798
Intangible assets, net 763,976 638,152
In-process research and development 644,713 792,275
Goodwill 704,603 743,348
Investments 41,139 34,716
Other assets 5,756 4,841
Total assets 2,766,619 2,799,188
Current liabilities:    
Accounts payable 53,360 72,535
Accrued expenses 197,955 167,899
Current portion of lines of credit and notes payable 11,981 11,468
Total current liabilities 263,296 251,902
2033 Senior Notes and estimated fair value of embedded derivatives, net of discount 43,701 48,986
Deferred tax liabilities, net 165,331 226,036
Other long-term liabilities, principally deferred revenue and line of credit 202,483 292,470
Total long-term liabilities 411,515 567,492
Total liabilities 674,811 819,394
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 558,576,051 and 546,188,516 shares issued at December 31, 2016 and 2015, respectively 5,586 5,462
Treasury Stock - 586,760 and 1,120,367 shares at December 31, 2016 and 2015, respectively (1,911) (3,645)
Additional paid-in capital 2,845,096 2,705,385
Accumulated other comprehensive loss (27,009) (22,537)
Accumulated deficit (729,954) (704,871)
Total shareholders’ equity 2,091,808 1,979,794
Total liabilities and equity $ 2,766,619 $ 2,799,188